Relmada Therapeutics, Inc. (RLMD)
NASDAQ: RLMD · Real-Time Price · USD
6.65
+0.13 (1.99%)
At close: Jun 12, 2026, 4:00 PM EDT
6.78
+0.13 (1.95%)
After-hours: Jun 12, 2026, 5:15 PM EDT
Relmada Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $12 | Buy | Maintains | $12 | +80.45% | May 13, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Reiterates $19 | Buy | Reiterates | $19 | +185.71% | May 13, 2026 |
| Lucid Capital | Lucid Capital | Buy Initiates $14 | Buy | Initiates | $14 | +110.53% | Mar 2, 2026 |
| Leerink Partners | Leerink Partners | Buy Initiates $8 | Buy | Initiates | $8 | +20.30% | Jan 23, 2026 |
| Jefferies | Jefferies | Buy Initiates $9 | Buy | Initiates | $9 | +35.34% | Dec 22, 2025 |